In efforts to boost innovation, pharma and med-tech sectors in India seek a 10% allocation from the National Research Fund, reinstatement of 200% weighted deductions for R&D, and tax incentives for AI research in the Union Budget. They also call for reduced import duties and GST on medical devices to enhance affordability and ensure quality healthcare for patients.